Literature DB >> 17084831

Impairment of mitochondrial respiratory chain enzyme activities in tetralogy of Fallot.

Santosh B Shinde1, Vipul C Save, Neela D Patil, Kaushala P Mishra, Anil G Tendolkar.   

Abstract

BACKGROUND: During the last decade, disorders of the respiratory chain, so-called mitochondrial disorders, have emerged as a major clinical entity. Tetralogy of fallot (TOF) children>2 month of age are at risk for postoperative myocardial contractile failure. Myocardial ischemia is associated with a reduction in mitochondrial enzyme activity and have impaired metabolism resulting in decreased postoperative myocardial adenosine triphosphate (ATP) concentrations and increased lactate levels. With this in view, we measured the mitochondrial energy system (respiration and OXPHOS) and to study morphological changes from the right ventricular outflow tract (RVOT) muscle of patients with TOF.
METHODS: 30 infants with TOF were studied with age-matched control group consisted of 12 normal patients who died due to extracardiac causes. Mitochondrial respiratory chain complexes, OXPHOS, cytochrome content and ATPase activity were measured by documented standard procedure. Morphological changes examined with a transmission electron microscope.
RESULTS: In the presence of glutamate and succinate as substrates, the rate of mitochondrial oxygen consumption was significantly lower in RVOT muscles (p<0.001) by using with and without addition of ADP. The ADP/O ratio indices for glutamate and succinate were not significantly affected. The activities of rotenone-sensitive NADH cytochrome c reductase (complexes I+III), cytochrome c oxidase (complex IV) and the ratio of I and III to II and III complexes (complex I) were significantly lower in TOF (p<0.001). A significant reduction of total cytochrome content and ATPase activity (p<0.001) was noted in study group. Morphological changes were also seen in study group as compared with control.
CONCLUSIONS: OXPHOS, mitochondrial respiratory chain complex I, I+III and IV, cytochrome content and ATPase activity are more impaired in RVOT muscles in patients with TOF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084831     DOI: 10.1016/j.cca.2006.09.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Identification of differently expressed genes and small molecule drugs for Tetralogy of Fallot by bioinformatics strategy.

Authors:  Qiang Gu; Xue-Tao Chen; Ying-Bin Xiao; Lin Chen; Xue-Feng Wang; Jun Fang; Bai-Cheng Chen; Jia Hao
Journal:  Pediatr Cardiol       Date:  2014-01-25       Impact factor: 1.655

2.  Alteration of cardiolipin biosynthesis and remodeling in single right ventricle congenital heart disease.

Authors:  Anastacia M Garcia; Jessica C McPhaul; Genevieve C Sparagna; Danielle A Jeffrey; Raleigh Jonscher; Sonali S Patel; Carmen C Sucharov; Brian L Stauffer; Shelley D Miyamoto; Kathryn C Chatfield
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-14       Impact factor: 4.733

Review 3.  Mitochondria in the human heart.

Authors:  H Lemieux; C L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 4.  Mitochondria in cardiac hypertrophy and heart failure.

Authors:  Mariana G Rosca; Bernard Tandler; Charles L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2012-09-13       Impact factor: 5.000

5.  Gene expression analysis in cardiac tissues from infants identifies candidate agents for Tetralogy of Fallot.

Authors:  Dicheng Yang; Jing Li; Zhongxiang Yuan
Journal:  Pediatr Cardiol       Date:  2013-04-07       Impact factor: 1.655

Review 6.  Mitochondrial dysfunction in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.